Literature DB >> 25239852

Synthesis and evaluation of new 3-phenylcoumarin derivatives as potential antidepressant agents.

Koneni V Sashidhara1, K Bhaskara Rao2, Seema Singh3, Ram K Modukuri2, G Aruna Teja3, Hardik Chandasana4, Shubha Shukla3, Rabi S Bhatta4.   

Abstract

A series of amine substituted 3-phenyl coumarin derivatives were designed and synthesized as potential antidepressant agents. In preliminary screening, all compounds were evaluated in forced swimming test (FST), a model to screen antidepressant activity in rodents. Among the series, compounds 5c and 6a potentially decreased the immobility time by 73.4% and 79.7% at a low dose of 0.5 mg/kg as compared to standard drug fluoxetine (FXT) which reduced the immobility time by 74% at a dose of 20 mg/kg, ip. Additionally, these active compounds also exhibited significant efficacy in tail suspension test (TST) (another model to screen antidepressant compounds). Interestingly, rotarod and locomotor activity tests confirmed that these two compounds do not have any motor impairment effect and neurotoxicity in mice. Our studies demonstrate that the new 3-phenylcoumarin derivatives may serve as a promising antidepressant lead and hence pave the way for further investigation around this chemical space.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coumarin; Depression; Forced swim test; Tail suspension test

Mesh:

Substances:

Year:  2014        PMID: 25239852     DOI: 10.1016/j.bmcl.2014.08.037

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Anibamine and Its Analogues: Potent Antiplasmodial Agents from Aniba citrifolia.

Authors:  Yongle Du; Ana Lisa Valenciano; Yumin Dai; Yi Zheng; Feng Zhang; Yan Zhang; Jason Clement; Michael Goetz; David G I Kingston; Maria B Cassera
Journal:  J Nat Prod       Date:  2019-10-02       Impact factor: 4.050

Review 2.  Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.

Authors:  Saad Alghamdi; Shaheed Ur Rehman; Nashwa Talaat Shesha; Hani Faidah; Muhammad Khurram; Sabi Ur Rehman
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

Review 3.  3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.

Authors:  Maria J Matos; Eugenio Uriarte; Lourdes Santana
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

Review 4.  Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.

Authors:  Qiang Zhang; Yu-Hang Miao; Teng Liu; Yin-Ling Yun; Xiao-Ya Sun; Tao Yang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

5.  A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis.

Authors:  Asma Farjallah; Laurent R Chiarelli; Martin Forbak; Giulia Degiacomi; Mathieu Danel; Fernanda Goncalves; Chantal Carayon; Cendrine Seguin; Marco Fumagalli; Monika Záhorszká; Elodie Vega; Souhir Abid; Anna Grzegorzewicz; Mary Jackson; Antonio Peixoto; Jana Korduláková; Maria Rosalia Pasca; Christian Lherbet; Stefan Chassaing
Journal:  ACS Infect Dis       Date:  2021-02-22       Impact factor: 5.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.